Seqens

Seqens is owned by SK Capital. SK Capital has a direct presence in 4 countries.

SK Capital has 8 subsidiaries including Geon Performance Solutions, Lacerta Group and PCAS.

They are in:

• Chemicals56%
• Holding11%
• Other33%

Acquisition, funding and merger involving SK Capital.

• SK Capital has acquired Seqens (posted on July 20 2022).

View the org chart displaying its 31 main executives

Most searched biographies at Seqens

• Pierre Luzeau, Chief Executive Officer
• Jayesh Taunk, Director
• Dina Bouzoubaa, Director

Create your alert
to follow the executive moves at Seqens.

SK Capital has 1,143 competitors including BASF (Germany), AkzoNobel (Netherlands) and Air Liquide (France).

Popular M&A news in Chemicals

• Agrofresh Solutions has announced the acquisition of Pace International  (posted on April 2 2024).
• Orica has announced the acquisition of Cyanco  (posted on February 26 2024).
• Novozymes and Chr. Hansen have merged  (posted on January 29 2024)..

Popular contacts in Chemicals

• Miriam Haran - Director at ICL
• Philippe Amon - President and Chief Executive Officer at SICPA
• Jean-Marc Gilson - Director, President and Chief Executive Officer at Mitsubishi Chemical Holdings

Learn more about the Chemicals industry >

Press releases by Seqens

• Press kit : Safety is at the heart of our activities - Seqens
• Press / Media - Seqens
• Newsroom - Seqens
• LinkedIn Login, Sign in | LinkedIn
• https://twitter.com/intent/tweet?text=https%3A%2F%2Fwww.seqens.com%2Fen%2Fnewsroom

Social media about Seqens

• Seqens on Wikipedia, Google News & Yahoo Finance
• Seqens on LinkedIn, Twitter & YouTube

Contact by email its executives including Pierre Luzeau

Call Seqens at +33 42...

View the org chart

Register to receive your alert

Report an error